Octreotide in bronchobiliary fistula management

Ann Thorac Surg. 2004 Oct;78(4):1512-3; author reply 1513. doi: 10.1016/j.athoracsur.2003.10.137.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adenocarcinoma / complications
  • Adenocarcinoma / secondary
  • Aged
  • Biliary Fistula / drug therapy*
  • Biliary Fistula / surgery
  • Biliary Tract Neoplasms / complications
  • Biliary Tract Neoplasms / secondary
  • Bronchial Fistula / drug therapy*
  • Bronchial Fistula / surgery
  • Cholangiopancreatography, Endoscopic Retrograde
  • Combined Modality Therapy
  • Fatal Outcome
  • Female
  • Heart Arrest / etiology
  • Humans
  • Intraoperative Complications / etiology
  • Middle Aged
  • Octreotide / therapeutic use*
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / surgery
  • Shock, Hemorrhagic / etiology
  • Stents
  • Vena Cava, Inferior / injuries

Substances

  • Octreotide